During the past decade, Delray Eye Associates, PA conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Delray Eye Associates, PA" #1 collaborator was "National Eye Institute (NEI)" with 1 trials as a collaborator and "National Institutes of Health (NIH)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Delray Eye Associates, PA" are "Corneal Ectasia" (1 trials), "Herpes Zoster Ophthalmicus" (1 trials) and "Keratoconus" (1 trials). Many other conditions were trialed in "Delray Eye Associates, PA" in a lesser frequency.

Most popular intervention types in "Delray Eye Associates, PA" are "Drug" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "KXL System (15 mW/cm2)" (1 trials), "KXL System (30 mW/cm2)" (1 trials), "KXL System (45 mW/cm2)" (1 trials), "Masked Oral Valacyclovir" (1 trials) and "Masked Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Delray Eye Associates, PA" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Delray Eye Associates, PA". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Delray Eye Associates, PA, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Delray Eye Associates, PA, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".